Sulfinpyrazone
A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties. (In Vitro) :Sulfinpyrazone (G-28315) stimulates fibrinolytic activity. (In Vivo) :In rats with kaolin-induced paw oedema, Sulfinpyrazone (G-28315) is able to restore the markedly prolonged euglobulin clot lysis time in an oral dose of 30 mg/kg. Beside these effects, Sulfinpyrazone protects rabbits from arachidonate-induced sudden death after a single oral dose of 10-30 mg/kg.
Product Specifications
CAS Number
57-96-5
Product Name Alternative
G-28315 | NSC 75925
Field of Research
Pharmacology & Drug Discovery
Purity
>98% (HPLC)
Solubility
Soluble in DMSO
Smiles
O=C (C1CCS (C2=CC=CC=C2) =O) N (C3=CC=CC=C3) N (C4=CC=CC=C4) C1=O
Molecular Formula
C23H20N2O3S
Molecular Weight
404.48
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
1,2-diphenyl-4- (2- (phenylsulfinyl) ethyl) pyrazolidine-3,5-dione
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Recombinant Chemokine C-C-Motif Receptor 4 (CCR4)
Recombinant Chemokine C-C-Motif Receptor 4 (CCR4)
Recombinant Chemokine C-C-Motif Receptor 4 (CCR4)
Recombinant Chemokine C-C-Motif Receptor 4 (CCR4)
Recombinant Chemokine C-C-Motif Receptor 4 (CCR4)